For Healthcare professionals
Report adverse event
Ov
erlay Text
Prescribing Information
Important Product Safety Information
Safety Information
Description
Publish Date
LINKS
Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck
15/02/2024
Relenza powder for inhalation
Zanamivir
-
Important safety information on Non-steroidal anti-inflammatory drugs (NSAlDs) in Burkina Faso
11/06/2021